You are here:

duloxetine (Cymbalta)


In the absence of a submission from the holder of the marketing authorisation.

duloxetine (Cymbalta®) is not recommended for use within NHSScotland for the treatment of generalised anxiety disorder.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: duloxetine (Cymbalta)
SMC Drug ID: 514/08
Manufacturer: Eli Lilly and Company Ltd
Indication: Generalised anxiety disorder
BNF Category:
Sub Category: 4.3 Antidepressant drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 October 2008